| Ipomoeassin F binds Sec61α to inhibit protein translocation G Zong, Z Hu, S O’keefe, D Tranter, MJ Iannotti, L Baron, B Hall, ... Journal of the American Chemical Society 141 (21), 8450-8461, 2019 | 64 | 2019 |
| Total Synthesis and Biological Evaluation of Ipomoeassin F and Its Unnatural 11R-Epimer G Zong, E Barber, H Aljewari, J Zhou, Z Hu, Y Du, WQ Shi The Journal of organic chemistry 80 (18), 9279-9291, 2015 | 53 | 2015 |
| Revealing the pharmacophore of ipomoeassin F through molecular editing G Zong, H Aljewari, Z Hu, WQ Shi Organic letters 18 (7), 1674-1677, 2016 | 32 | 2016 |
| Role of Kasai procedure in surgery of hilar bile duct strictures JB Gao, LS Bai, ZJ Hu, JW Wu, XQ Chai World Journal of Gastroenterology: WJG 17 (37), 4231, 2011 | 27 | 2011 |
| Primary hepatic carcinoid tumor J Gao, Z Hu, J Wu, L Bai, X Chai World Journal of Surgical Oncology 9, 1-4, 2011 | 25 | 2011 |
| Synergistic contribution of tiglate and cinnamate to cytotoxicity of ipomoeassin F G Zong, L Whisenhunt, Z Hu, WQ Shi The Journal of organic chemistry 82 (9), 4977-4985, 2017 | 23 | 2017 |
| Ring expansion leads to a more potent analogue of Ipomoeassin F G Zong, Z Hu, KB Duah, LE Andrews, J Zhou, S O’Keefe, L Whisenhunt, ... The Journal of organic chemistry 85 (24), 16226-16235, 2020 | 18 | 2020 |
| Design, synthesis and biological evaluation of fucose-truncated monosaccharide analogues of ipomoeassin F G Zong, M Hirsch, C Mondrik, Z Hu, WQ Shi Bioorganic & medicinal chemistry letters 27 (12), 2752-2756, 2017 | 16 | 2017 |
| New insights into structure–activity relationship of ipomoeassin F from its bioisosteric 5-oxa/aza analogues G Zong, X Sun, R Bhakta, L Whisenhunt, Z Hu, F Wang, WQ Shi European journal of medicinal chemistry 144, 751-757, 2018 | 12 | 2018 |
| Liver biopsy hydroxyproline content is a diagnostic for hepatocellular carcinoma in murine models of nonalcoholic steatohepatitis TL Bissoondial, Y Han, S Mullan, AK Pabla, K Spahn, S Shi, L Zheng, ... Diagnostics 10 (10), 784, 2020 | 8 | 2020 |
| Glycerol-3-phosphate acyltransferase1 is a model-agnostic node in nonalcoholic fatty liver disease: implications for drug development and precision medicine K Liao, AJ Pellicano, K Jiang, N Prakash, J Li, S Bhutkar, Z Hu, Q Ali, ... ACS omega 5 (29), 18465-18471, 2020 | 8 | 2020 |
| 胆总管囊肿再次手术 11 例分析 胡志坚， 柴新群， 柏立山， 叶伦， 冯贤松 肝胆外科杂志 19 (3), 174-176, 2011 | 5 | 2011 |
| Hepatectomy for hepatolithiasis among patients with a history of biliary surgery JB Gao, WJ Shi, ZJ Hu, LS Bai, XQ Chai Int J Clin Exp Med 9 (7), 13184-13189, 2016 | 4 | 2016 |
| 老年人胆道再次手术的术前评估及处理 胡志坚， 柴新群， 柏立山， 吴军卫 肝胆外科杂志 20 (2), 131-134, 2012 | 4 | 2012 |
| 胆道多次手术合并肝硬化门静脉高压症的评估及处理 柏立山， 柴新群， 胡志坚， 冯贤松 肝胆胰外科杂志 23 (003), 202-204, 2011 | 4 | 2011 |
| The protective effect of H151, a novel STING inhibitor, in renal ischemia-reperfusion-induced acute kidney injury Z Hu, F Zhang, M Brenner, A Jacob, P Wang American Journal of Physiology-Renal Physiology 324 (6), F558-F567, 2023 | 2 | 2023 |
| 内地发现肝包虫病复发 1 例 柏立山， 胡志坚， 柴新群 肝胆外科杂志 19 (3), 240-240, 2011 | 2 | 2011 |
| Synthesis, Biological Evaluation and Docking Studies of Ring-Opened Analogues of Ipomoeassin F S O’Keefe, P Bhadra, KB Duah, G Zong, L Tenay, L Andrews, ... Molecules 27 (14), 4419, 2022 | 1 | 2022 |
| Targeting Collagen Type III in Proteinuric Kidney Disease: Informing Drug Potential Using the Jaccard–Tanimoto Index M Liu, A Dalvi, S Dalapati, N Prakash, Z Hu, P Zhou, K Jiang, A Pellicano, ... Processes 8 (8), 996, 2020 | 1 | 2020 |
| Novel Rho associated coiled kinase 2 (ROCK2) inhibitor reduces steatosis and fibrosis in mice model of liver disease Q Ali, S Dalapati, N Prakash, P Narayan, L Paka, JS Li, ZJ Hu, I Goldberg The FASEB Journal 34 (S1), 1-1, 2020 | 1 | 2020 |
